
Sign up to save your podcasts
Or


Christophe Mariat, from Saint-Étienne, France, and Chair of the ERA DESCaRTES Working Group, takes us through the complex topic of adapting anti-rejection treatment in the context of a failing renal graft. He shares valuable insights on renal graft survival rates, strategies for adjusting immunosuppressive treatments when the kidney starts failing, and the adaptations needed in antirejection strategies once dialysis is resumed.
By European Renal Association3
22 ratings
Christophe Mariat, from Saint-Étienne, France, and Chair of the ERA DESCaRTES Working Group, takes us through the complex topic of adapting anti-rejection treatment in the context of a failing renal graft. He shares valuable insights on renal graft survival rates, strategies for adjusting immunosuppressive treatments when the kidney starts failing, and the adaptations needed in antirejection strategies once dialysis is resumed.

7,613 Listeners

323 Listeners

499 Listeners

3,360 Listeners

1,146 Listeners

14 Listeners

368 Listeners

172 Listeners

84 Listeners

375 Listeners

8 Listeners

135 Listeners

319 Listeners